MARKET

DBVT

DBVT

Dbv Technologies S A
NASDAQ
14.27
+0.79
+5.86%
After Hours: 14.27 0 0.00% 16:10 08/10 EDT
OPEN
13.46
PREV CLOSE
13.48
HIGH
14.54
LOW
13.36
VOLUME
474.06K
TURNOVER
--
52 WEEK HIGH
26.19
52 WEEK LOW
8.70
MARKET CAP
844.96M
P/E (TTM)
-4.7399
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at DBVT last week (0803-0807)?
Weekly Report · 15h ago
Weekly Report: what happened at DBVT last week (0727-0731)?
Weekly Report · 08/03 10:12
DBV Technologies announces sale of $50M of ADSs through ATM program
TipRanks · 07/30 21:45
Weekly Report: what happened at DBVT last week (0720-0724)?
Weekly Report · 07/27 10:17
DBV Technologies: Regulatory Noise, Commercial Misperception, And A Deep Valuation Gap
Seeking Alpha · 07/26 12:23
DBV Technologies: Viaskin's FDA Path Still Leaves Room For More Upside
Seeking Alpha · 07/23 20:46
Fourteen new option listings and one option delisting on July 22nd
TipRanks · 07/22 12:30
Weekly Report: what happened at DBVT last week (0713-0717)?
Weekly Report · 07/20 10:13
More
About DBVT
DBV Technologies SA is a France-based clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a technology platform called Vaskin. The Company's therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin. It dedicates its technology to treat patients, including infants and children, suffering from severe food allergies, for whom safety is paramount, since the introduction of the offending allergen into their bloodstream can cause severe or life-threatening allergic reactions, such as anaphylactic shock. The Company's product portfolio for allergy treatments consists of Viaskin Peanut, Viaskin Milk and Viaskin Egg. The Company operates one subsidiary DBV Technologies Inc. in the United States.

Webull offers DBV Technologies SA - ADR stock information, including NASDAQ: DBVT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DBVT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DBVT stock methods without spending real money on the virtual paper trading platform.